To explore this issue specifically in the context of human T-ALL, we elected to test prospectively the ability of candidate downstream signaling elements to render previously sensitive cell lines resistant to IGF1R inhibition. This evidence concerns the gene IGF1R and acute lymphoblastic leukemia.